EUVIMEDEUVIMED entdecken
Crossref

Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression

Weiye Zhu, Xiao Gui, Yukun Zhou, Xin Gao, Rui Zhang, Qing Li, Haorui Zhang, Jiawei Zhao, Xiao Cui, Guangping Gao, Huipeng Tang, Chenyang Huan und 4 weitere

Experimental Eye Research · 2024

DOI: 10.1016/j.exer.2023.109753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2024. Verfasst von Weiye Zhu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Changhai Hospital, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Organophosphates, Quinazolines, Retinal Diseases, Retinal Neovascularization. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Hospital Development Center, Naval Medical Center San Diego.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The detrimental effects of pathological angiogenesis on the visual function are indisputable. Within a prominent role in chromosome segregation and tumor progression, aurora kinase B (AURKB) assumes a prominent role. However, its role in pathological retinal angiogenesis remains unclear. This study explores this latent mechanism. METHODS: To inhibit AURKB expression, we designed specific small interfering RNAs targeting AURKB and transfected them into vascular endothelial cells. Barasertib was selected as the AURKB inhibitor. The anti-angiogenic effects of both AURKB siRNA and barasertib were assessed in vitro by cell proliferation, transwell migration, and tube formation. To evaluate the angiogentic effects of AURKB in vivo, neonatal mice were exposed to 75% oxygen followed by normoxic repositioning to establish an oxygen-induced retinopathy (OIR) model. Subsequently, phosphate-buffered saline and barasertib were administered into OIR mice via intravitreal injection. The effects of AURKB on cell cycle proteins were determined by western blot analysis. RESULTS: We found that AURKB was overexpressed during pathological angiogenesis. AURKB siRNA and barasertib significantly inhibited endothelial cell proliferation, migration, and tube formation in vitro. Furthermore, AURKB inhibition attenuated retinal angiogenesis in the OIR model. A possible mechanism is the disruption of cell cycle by AURKB inhibition. CONCLUSION: In conclusion, AURKB significantly influenced pathological retinal angiogenesis, thereby presenting a promising therapeutic target in ocular neovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganophosphatesQuinazolinesRetinal DiseasesRetinal NeovascularizationAnimalsMiceAngiogenesisAurora Kinase BCell DivisionCell ProliferationEndothelial CellsMice, Inbred C57BLNeovascularization, PathologicOxygenRNA, Small Interfering

Stichwörter der Autor:innen

AURKBCell cycle arrestOIR modelPathological retinal angiogenesis

Substanzen

2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethy…Aurora Kinase BOrganophosphatesOxygenQuinazolinesRNA, Small InterferingAurkb protein, mouse

Autor:innen und Institutionen

  • Department of Ophthalmology, Shanghai Changhai Hospital, Shanghai, 200433, China.
  • Department of Ophthalmology, 92493 Hospital, Huludao, 125004, China; Department of Ophthalmology, PLA Naval Medical Center, Shanghai, 200050, China.
  • Department of Ophthalmology, PLA Naval Medical Center, Shanghai, 200050, China. Electronic address: zhouzhe1212@163.com.
  • Department of Ophthalmology, Shanghai Changhai Hospital, Shanghai, 200433, China. Electronic address: shenwei@smmu.edu.cn.

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Municipal Hospital Development Center
  • Naval Medical Center San Diego
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, W., Gui, X., Zhou, Y., Gao, X., Zhang, R., Li, Q., Zhang, H., Zhao, J., Cui, X., Gao, G., Tang, H., Huan, C., Pan, D., Song, H., Zhou, Z., & Shen, W. (2024). Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression. Experimental Eye Research. https://doi.org/10.1016/j.exer.2023.109753

Vancouver

Zhu W, Gui X, Zhou Y, Gao X, Zhang R, Li Q, et al. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression. Experimental Eye Research. 2024. doi:10.1016/j.exer.2023.109753

BibTeX
@article{Zhu2024,
  author = {Zhu, Weiye and Gui, Xiao and Zhou, Yukun and Gao, Xin and Zhang, Rui and Li, Qing and Zhang, Haorui and Zhao, Jiawei and Cui, Xiao and Gao, Guangping and Tang, Huipeng and Huan, Chenyang and Pan, Dongyan and Song, Hongyuan and Zhou, Zhe and Shen, Wei},
  title = {Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression},
  journal = {Experimental Eye Research},
  year = {2024},
  doi = {10.1016/j.exer.2023.109753}
}
Kostenlos starten →